Stopping of adalimumab in juvenile idiopathic arthritis-associated uveitis (ADJUST): a multicentre, double-masked, randomised controlled trial. The Lancet. 2025; 405:303-313.
.Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. Rheumatology. 2025; 64:32-44.
.Lack of HLH in FMF. Pediatric Rheumatology Online Journal. 2025; 23:14.
.Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open-Label, Phase 1 Trial. Arthritis Care and Research. 2025; 77:584-593.
.Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study. Lupus Science and Medicine. 2025; 12:e001484.
.Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction. Arthritis Care and Research. 2025; 77:513-521.
.Sonographic and Disease Activity Findings Related With Medication Change in JIA: A Historical Cohort Study. Journal of Clinical Rheumatology: practical reports on rheumatic and musculoskeletal disease. 2025; 31:20-25.
.A practical approach to uveitis screening in children with juvenile idiopathic arthritis. British Journal of Ophthalmology. 2025; 109:372-376.
.Pediatric Society of the African League Against Rheumatism juvenile idiopathic arthritis recommendations for enthesitis-related arthritis and juvenile psoriatic arthritis. Clinical Rheumatology. 2025; 44:901-922.
.Multidisciplinary approach to treating complex immune dysregulation disorders: an adaptive model for institutional implementation. Frontiers in Immunology. 2025; 16:1519955.
.Comparative Effectiveness and Safety of the JAK Inhibitors and Biologic Disease-Modifying Antirheumatic Drugs in Treating Children With Nonsystemic Juvenile Idiopathic Arthritis: A Bayesian Meta-Analysis of Randomized Controlled Trials. ACR Open Rheumatology. 2025; 7:e11788.
.Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers. Arthritis and Rheumatology. 2025; 77:596-605.
.Candidate Tear-Based Uveitis Biomarkers in Children with JIA Based on Arthritis Activity and Topical Corticosteroid Use. Ocular Immunology and Inflammation (Informa). 2025; 33:603-612.
.Achieving Medication-Free Remission in Patients With Juvenile Dermatomyositis. ACR Open Rheumatology. 2025; 7:e11751.
.Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study. The Lancet. Rheumatology. 2025; 7:e243-e251.
.2025; 29:105184.
. 386 Unmet Psychosocial Needs in Pain Care for Pediatric Rheumatic Diseases: A Qualitative Inquiry. Journal of Pain.Elsevier; Elsevier; 2025.
. Systemic lupus erythematosus in childhood and adolescence. Dubois' Lupus Erythematosus and Related Syndromes. :Elsevier; Elsevier; 2025.
. 41 Systemic lupus erythematosus in childhood and adolescence. Dubois' Lupus Erythematosus and Related Syndromes. :Implementation of the Lupus Low Disease Activity State in Pediatric Rheumatology Care: The Role of the Visual Analog Scale. ACR Open Rheumatology. 2025; 7:e11737.
.Catastrophic antiphospholipid antibody syndrome associated with ischaemic cardiomyopathy. Cardiology in the Young. 2025; 34:2706-2708.
.Occupational and Hobby Exposures Associated With Myositis Phenotypes in a National Myositis Patient Registry. Arthritis Care and Research. 2025; 77:104-115.
.Effect of an Electronic Pill Bottle on Hydroxychloroquine Adherence in Pediatric Lupus: Results of a Novel Direct-to-Family Pilot Trial. ACR Open Rheumatology. 2025; 7:e11780.
.Juvenile Idiopathic Arthritis and Spondylarthritis. Seminars in Musculoskeletal Radiology. 2025; 29:249-266.
.Development of CARRA/PReS-endorsed consensus Core and Expanded Datasets in childhood-onset systemic lupus erythematosus for international registry-based research. Annals of the Rheumatic Diseases. 2025; 84:158-168.
.25 Years of Biologics for the Treatment of Pediatric Rheumatic Disease: Advances in Prognosis and Ongoing Challenges. Arthritis Care and Research. 2025; 77:573-583.
.Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study. Arthritis Care and Research. 2025; 77:38-49.
.